Skip to search.
 FTSE 100 Up 0.60%

AbbVie Inc. (ABBV)

-NYSE
66.10 Up 0.62(0.95%) 26 May 21:01
Add to Portfolio
Prev Close:65.48
Open:65.72
Bid:66.70 x 300
Ask:66.75 x 200
1y Target Est:72.73
Beta:1.63
Earnings Date:23 Jul - 27 Jul (Est.)
Day's Range:65.66 - 67.00
52wk Range:51.37 - 70.76
Volume:21,041,245
Avg Vol (3m):11,805,300
Market Cap:105.24b
P/E (ttm):59.02
EPS (ttm):1.12
Div & Yield:2.04 (3.10%)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ABBVUp 0.95%105.24b
MRKDown 0.69%166.60b
NVSDown 1.96%246.42b
PFEDown 0.50%210.04b

Key Statistics

Forward P/E (1 yr):13.38
P/S (ttm):5.10
Ex-Dividend Date:13-Apr-15

Analysts

Annual EPS Est (Dec-15) :4.23
Quarterly EPS Est (Jun-15) :1.05
Mean Recommendation*:2.2
PEG Ratio (5 yr expected):1.05

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceutical products worldwide. The company’s products include HUMIRA, a biologic therapy administered as a subcutaneous injection to treat autoimmune diseases; VIEKIRA PAK, an all-o... more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback